CompoAtlas

GTF-Chroma Cinn

Natural health product licensed in Canada

Other names
Health First GTF Chroma-Cinn
Licence holder
Health First Network
NPN or DIN-HM
80090611
Status
Active licence
Licence date
14 February 2019
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Chrome

Source : Nicotinate de chrome (III)

200 microgrammesNot calculated
Chrome

Source : Diglycinate de chrome (III)

200 microgrammesNot calculated
Cinnamomum aromaticum

Source : Écorce (branche)

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 250 milligramme

25 milligrammeNot calculated

Non-medicinal ingredients

Dioxyde de silicium colloïdal, Stéarate de magnésium, Cellulose microcristalline, Hypromellose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule2 days

Uses authorised in Canada

Helps to maintain good health. Provides support for healthy glucose metabolism. Helps the body to metabolize carbohydrates and fats. Helps to prevent chromium deficiency.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80090611

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line